Sign In
Buy SNN
$29.36
-0.120 (-0.407%)
At Close: Jun 02, 2026
Smith & Nephew Stock Is Trading Lower Despite Posting Surge In Q2 Revenues, Profit
07:03am, Thursday, 29'th Jul 2021
Smith & Nephew Plc (NYSE: SNN) revenues soared in Q2 as COVID-19 restrictions eased and levels of elective surgery returned towards normal in many markets. The Company reported revenues of $1.3 bil
Smith+Nephew's (SNN) New Device to Boost Patient Outcomes
10:06am, Monday, 12'th Jul 2021
Smith+Nephew's (SNN) FAST-FLIX FLEX Meniscal Repair System to provide long-term benefits to patients.
LONDON, July 7, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its FAST-FIX FLEX Meniscal Repair System, the only device
Smith & Nephew growth drivers underappreciated, says Credit Suisse
06:47am, Wednesday, 09'th Jun 2021
Smith & Nephew PLC's (LON:SN) growth drivers are “underappreciated” according to analysts at Credit Suisse, who have upgraded the stock to ‘outperform' from ‘neutral' and upped their target pr
LONDON, April 30, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, announces the publication of new research showing that clinicians estimated that 45% of
Smith & Nephew sees the light at the end of the tunnel
03:12am, Thursday, 29'th Apr 2021
Smith & Nephew PLC (LON:SN.) reinstated full-year guidance as visibility is improving thanks to the COVID-19 vaccine rollout programmes and healthcare systems reopening to non-urgent surgery.
Smith & Nephew plc (SNN) CEO Roland Diggelmann on Q4 2020 Results - Earnings Call Transcript
08:29am, Thursday, 18'th Feb 2021
Smith & Nephew plc (SNN) CEO Roland Diggelmann on Q4 2020 Results - Earnings Call Transcript
Smith & Nephew Maintains Dividend For 2021 Despite Q4 Earnings Hit By COVID-19; Shares Drop
07:48am, Thursday, 18'th Feb 2021
Medical device maker Smith & Nephew plc (NYSE: SNN) slips in the premarket after reporting a slump in revenues and profits. Full-year 2020 revenue fell 11.2% Y/Y to $4.6 billion, and operating pr
Smith & Nephew suffers nasty fall
04:03am, Thursday, 18'th Feb 2021
Smith & Nephew PLC (LON:SN) saw its shares slide in early deals as it caught the market on the hop with a disappointing set of results. Shares in the wound care and knee & hip implants specialist were
Smith+Nephew's (SNN) PICO sNPWT Study Outcome Encouraging
09:02am, Thursday, 28'th Jan 2021
Smith+Nephew's (SNN) PICO Single Use Negative Pressure Wound Therapy System (sNPWT) considerably reduces surgical site infections complications and provides better patient outcome.
7 Stocks to Buy for a Continued Run with the Market Bulls
03:00pm, Tuesday, 05'th Jan 2021
The rally in 2020 may mean many stocks are not cheap any more, but long-term investors can still find robust stocks to buy in a bull market The post 7 Stocks to Buy for a Continued Run with the Market
Smith & Nephew: A Long-Term Buy And Hold In Medical Devices
08:20am, Monday, 09'th Nov 2020
Smith & Nephew has a solid, growing business which will grow with market growth as well as by acquisition. It has a decent dividend payment history.
7 Healthcare Stocks That Can Survive Massive Reform
10:23am, Monday, 02'nd Nov 2020
These seven healthcare stocks may represent robust long-term investments no matter how reforms in the sector may develop post-election. The post 7 Healthcare Stocks That Can Survive Massive Reform app
Smith & Nephew plc (SNN) CEO Roland Diggelmann on Q3 2020 Results - Earnings Call Transcript
03:10pm, Thursday, 29'th Oct 2020
Smith & Nephew plc (SNN) CEO Roland Diggelmann on Q3 2020 Results - Earnings Call Transcript
